These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11503956)

  • 21. [Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].
    Shen Y; Xue Y; Li J; Pan J; Wu Y; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):160-3. PubMed ID: 12673589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytogenetics of myelodysplastic syndromes and its impact as prognostic factor].
    Borjas-Gutiérrez C; Domínguez-Cruz MD; González-García JR
    Rev Med Inst Mex Seguro Soc; 2017; 55(4):481-489. PubMed ID: 28591503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes].
    Raynaud SD
    Pathol Biol (Paris); 2003 Aug; 51(6):346-55. PubMed ID: 12927892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].
    Gao DG; Li BT; Zhou LN; Chen H; Zhang B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1190-4. PubMed ID: 24156432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelodysplastic syndrome: review of the cytogenetic and molecular data.
    Mhawech P; Saleem A
    Crit Rev Oncol Hematol; 2001 Dec; 40(3):229-38. PubMed ID: 11738946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization:  Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes.
    He R; Wiktor AE; Durnick DK; Kurtin PJ; Van Dyke DL; Tefferi A; Patnaik MS; Ketterling RP; Hanson CA
    Am J Clin Pathol; 2016 Jul; 146(1):86-94. PubMed ID: 27353768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic studies of a series of 43 consecutive secondary myelodysplastic syndromes/acute myeloid leukemias: conventional cytogenetics, FISH, and multiplex FISH.
    Shali W; Hélias C; Fohrer C; Struski S; Gervais C; Falkenrodt A; Leymarie V; Lioure B; Raby P; Herbrecht R; Lessard M
    Cancer Genet Cytogenet; 2006 Jul; 168(2):133-45. PubMed ID: 16843103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic features of 5q deletion and 5q- syndrome in myelodysplastic syndrome in Korea; marker chromosomes proved to be chromosome 5 with interstitial deletion by fluorescence in situ hybridization.
    Lee HR; Oh B; Hong DS; Zang DY; Yoon HJ; Kim HJ; Kim I; Ahn JS; Cheong JW; Lee KA; Cho KS; Lee MH; Bang SM; Kim TY; Yun YM; Min YH; Lee YK; Lee DS;
    Cancer Genet Cytogenet; 2010 Dec; 203(2):193-202. PubMed ID: 21156233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular pathogenesis of the myelodysplastic syndromes.
    Pellagatti A; Boultwood J
    Eur J Haematol; 2015 Jul; 95(1):3-15. PubMed ID: 25645650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent chromatin rearrangements in myelodysplastic syndromes--what stands behind?
    Pagáčová E; Falk M; Falková I; Lukášová E; Michalová K; Oltová A; Raška I; Kozubek S
    Folia Biol (Praha); 2014; 60 Suppl 1():1-7. PubMed ID: 25369334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic Syndromes.
    Ai J; Visconte V; Tabarroki A; Hasrouni E; Hamilton BK; Mukherjee S; Kalaycio M; Sobecks R; Advani AS; Sekeres MA; Shetty S; Tiu RV
    Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):489-95. PubMed ID: 25977195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of cytogenetic abnormalities involving chromosomes 5,7 and 8 in myelodysplastic syndromes with fluorescence in situ hybridization and its clinical significance].
    Cai Y; Qin YW; Wang C; Yang J; Yan SK
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):6-10. PubMed ID: 17649717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
    Panani AD; Roussos C
    Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
    Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
    Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact.
    Bacher U; Haferlach T; Schnittger S; Zenger M; Meggendorfer M; Jeromin S; Roller A; Grossmann V; Krauth MT; Alpermann T; Kern W; Haferlach C
    Br J Haematol; 2014 Mar; 164(6):822-33. PubMed ID: 24372512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.
    Harada H; Harada Y; Kimura A
    Curr Cancer Drug Targets; 2006 Sep; 6(6):553-65. PubMed ID: 17017876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes.
    Ohyashiki K; Ohyashiki JH; Iwabuchi A; Toyama K
    Leuk Lymphoma; 1996 Nov; 23(5-6):409-15. PubMed ID: 9031069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping.
    Martínez-Ramírez A; Urioste M; Alvarez S; Vizmanos JL; Calasanz MJ; Cigudosa JC; Benítez J
    Cancer Genet Cytogenet; 2004 Aug; 153(1):39-47. PubMed ID: 15325092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.